CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Charles River Laboratories International, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Charles River Laboratories International, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 28, 2024 was $69.7M, a 20.3% decline year-over-year.
  • Charles River Laboratories International, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 28, 2024 was $424M, a 10.8% decline year-over-year.
  • Charles River Laboratories International, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $475M, a 2.39% decline from 2022.
  • Charles River Laboratories International, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $486M, a 24.4% increase from 2021.
  • Charles River Laboratories International, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $391M, a 7.32% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $424M $69.7M -$17.7M -20.3% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-06
Q2 2024 $442M $94.1M -$2.94M -3.03% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $444M $73M -$30.2M -29.3% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $475M $187M -$326K -0.17% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-14
Q3 2023 $475M $87.4M -$9.08M -9.42% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $484M $97M -$12.3M -11.3% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-07
Q1 2023 $496M $103M +$10.1M +10.9% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-09
Q4 2022 $486M $187M +$49.8M +36.2% Sep 25, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $436M $96.5M -$6.95M -6.72% Jun 26, 2022 Sep 24, 2022 10-Q 2023-11-08
Q2 2022 $443M $109M +$20.9M +23.6% Mar 27, 2022 Jun 25, 2022 10-Q 2023-08-09
Q1 2022 $422M $93M +$31.5M +51.2% Dec 26, 2021 Mar 26, 2022 10-Q 2023-05-11
Q4 2021 $391M $138M -$5.61M -3.92% Sep 26, 2021 Dec 25, 2021 10-K 2024-02-14
Q3 2021 $397M $103M +$517K +0.5% Jun 27, 2021 Sep 25, 2021 10-Q 2022-11-02
Q2 2021 $396M $88.4M +$21M +31.2% Mar 28, 2021 Jun 26, 2021 10-Q 2022-08-03
Q1 2021 $375M $61.5M +$10.8M +21.2% Dec 27, 2020 Mar 27, 2021 10-Q 2022-05-04
Q4 2020 $364M $143M +$62.8M +78.2% Sep 27, 2020 Dec 26, 2020 10-K 2021-02-17
Q3 2020 $301M $103M +$30.1M +41.3% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-03
Q2 2020 $271M $67.4M +$23.7M +54.2% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-04
Q1 2020 $248M $50.8M -$4.36M -7.92% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-04
Q4 2019 $252M $80.3M +$20.7M +34.7% Sep 29, 2019 Dec 28, 2019 10-K 2021-02-17
Q3 2019 $231M $72.8M +$12.4M +20.6% Jun 30, 2019 Sep 28, 2019 10-K 2021-02-17
Q2 2019 $219M $43.7M -$9.98M -18.6% Mar 31, 2019 Jun 29, 2019 10-K 2021-02-17
Q1 2019 $229M $55.1M +$2.5M +4.75% Dec 30, 2018 Mar 30, 2019 10-K 2021-02-17
Q4 2018 $226M $59.7M +$89.5M Sep 30, 2018 Dec 29, 2018 10-K 2020-02-11
Q3 2018 $137M $60.4M +$7.89M +15% Jul 1, 2018 Sep 29, 2018 10-K 2020-02-11
Q2 2018 $129M $53.7M -$243K -0.45% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-11
Q1 2018 $129M $52.6M +$5.85M +12.5% Dec 31, 2017 Mar 31, 2018 10-K 2020-02-11
Q4 2017 $123M -$29.8M -$74.5M -167% Oct 1, 2017 Dec 30, 2017 10-K 2019-02-13
Q3 2017 $198M $52.5M +$14.7M +39.1% Jul 2, 2017 Sep 30, 2017 10-K 2019-02-13
Q2 2017 $183M $54M +$18.7M +53.2% Apr 2, 2017 Jul 1, 2017 10-K 2019-02-13
Q1 2017 $164M $46.8M +$9.64M +25.9% Jan 1, 2017 Apr 1, 2017 10-K 2019-02-13
Q4 2016 $155M $44.7M +$12.8M +40.1% Sep 25, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $142M $37.7M +$356K +0.95% Jun 26, 2016 Sep 24, 2016 10-Q 2017-11-09
Q2 2016 $142M $35.2M -$13.3M -27.4% Mar 27, 2016 Jun 25, 2016 10-Q 2017-08-09
Q1 2016 $155M $37.1M +$5.6M +17.8% Dec 27, 2015 Mar 26, 2016 10-Q 2017-05-10
Q4 2015 $149M $31.9M Sep 27, 2015 Dec 26, 2015 10-K 2018-02-13
Q3 2015 $37.4M Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-02
Q2 2015 $48.5M Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-03
Q1 2015 $31.5M Dec 28, 2014 Mar 28, 2015 10-Q 2016-05-04
Q2 2011 -$305M $32.3M +$17.9M +124% Mar 27, 2011 Jun 25, 2011 10-Q 2011-08-03
Q1 2011 -$323M $31.3M +$14M +80.3% Dec 26, 2010 Mar 26, 2011 10-Q 2011-05-04
Q4 2010 -$337M -$344M Sep 26, 2010 Dec 25, 2010 10-K 2011-02-23
Q3 2010 -$24.9M Jun 27, 2010 Sep 25, 2010 10-Q 2010-11-04
Q2 2010 $14.5M Mar 28, 2010 Jun 26, 2010 10-Q 2011-08-03
Q1 2010 $17.4M Dec 27, 2009 Mar 27, 2010 10-Q 2011-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.